BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 9.11 Delayed Data As of May 20 |  +0.08 / +0.89%Today’s Change | 7.61 Today|||52-Week Range 19.99 | -34.22% Year-to-Date |
Latest BCRX News | Press Releases
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC Buys 2, Sells 3 in 1st Quarter May 20 / GuruFocus News - Paid Partner Content | Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? May 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.03 |
| Today’s open | 9.08 |
| Day’s range | 8.67 - 9.20 |
| Volume | 220,528 |
| Average volume (3 months) | 4,927,466 |
| Market cap | $1.6B |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | +5.98% |
| Earnings growth (this year) | -25.86% |
| Earnings growth (next 5 years) | +4.47% |
| Revenue growth (last year) | +782.38% |
| P/E ratio | NM |
| Price/Sales | 15.78 |
| Price/Book | -- |
Competitors
Data as of 4:04pm ET, 05/20/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $157.2M |
| Annual profit (last year) | -$184.1M |
| Net profit margin | -117.11% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
